LUMIGAN® 0.01% (bimatoprost ophthalmic solution) is used
for the treatment of high eye pressure, also called intraocular pressure (IOP),
in people with open-angle glaucoma or ocular hypertension.
Important Safety Information
LUMIGAN® 0.01% (bimatoprost ophthalmic solution) has been
reported to cause darkening (pigmentation) of eye color, eyelid skin, and eyelashes
as well as increased growth of eyelashes. Pigmentation changes can increase as long
as LUMIGAN® 0.01% is used. After stopping LUMIGAN®
0.01%, darkening of eye color is likely to be permanent, while darkening
of the eyelid skin and eyelash changes may be reversible. The effects of increased
darkening beyond 5 years are not known.
When only one eye is treated, there is a possibility of eyelash changes in the eye
treated with LUMIGAN® 0.01%. These changes may result in
differences between the eyes in eyelash length, thickness, darkness, number of eyelashes,
and/or direction of eyelash growth. These changes are usually reversible upon stopping
LUMIGAN® 0.01% therapy.
Avoid allowing the tip of the dispensing bottle to touch the eye, anything around
the eye, fingers, or any other surface in order to avoid contamination by common
bacteria known to cause eye infections. Serious damage to the eye and loss of vision
may result from using contaminated solutions.
If you have eye surgery or develop any eye reactions (such as trauma or infection),
immediately consult with your physician about continuing the use of LUMIGAN®
If you wear contact lenses, remove them before using LUMIGAN® 0.01%.
Then wait 15 minutes after using LUMIGAN® 0.01% before you put your contacts back into your eyes.
The most common side effects are eye redness, growth of eyelashes, and itchy eyes.
for full prescribing information.
This site is intended for US residents only. No information on this site is provided with the intention to give medical advice or instructions on the accurate use of Allergan products. Allergan cannot answer unsolicited emails requesting personal medical advice; visitors should always consult a healthcare professional. Please visit the Allergan site for your country of residence for information concerning Allergan products and services available there.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
a Offer not valid for prescriptions reimbursed or paid under Medicare,
Medicaid, or any similar federal or state healthcare program, including any state medical or pharmaceutical
assistance programs. Void in the following states if any third-party payer reimburses you or pays for any part
of the prescription price: Massachusetts. Offer also void where prohibited by law, taxed, or restricted.
Amount of rebate not to exceed $25 for LUMIGAN® 0.01% or co-pay, whichever is less. This certificate may not be
reproduced and must accompany your request for a rebate. Offer good only for one prescription of LUMIGAN® 0.01%
(bimatoprost ophthalmic solution) per patient, per year, and only in the USA. Allergan, Inc., reserves the right to rescind,
revoke, and amend this offer without notice. You are responsible for reporting receipt of rebate to any private insurer that
pays for or reimburses you for any part of the prescription filled using this coupon.